Literature DB >> 7069591

Factors influencing the apparent protein binding of quinidine.

T W Guentert, S Oie.   

Abstract

Various factors influencing the apparent protein binding of quinidine were examined. Different binding values in rabbit plasma were obtained by equilibrium dialysis techniques employing three commonly used buffers. Binding values comparable to those found by ultrafiltration were achieved after dialysis against isotonic phosphate buffer for approximately 4 hr. Dialysis beyond 8 hr gave an increased free fraction with time. The reported effect of in vitro added heparin on plasma protein binding could be prevented by reducing the final concentration in blood from 20 to 5 U/ml, a concentration still sufficient to prevent clotting of the blood sample. Daily freezing and thawing of plasma samples over 1 week did not alter the binding of quinidine. The samples were stable for at least 2 months at -20 degrees.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7069591     DOI: 10.1002/jps.2600710316

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Pharmacokinetics of quinidine in male patients. A population analysis.

Authors:  C N Verme; T M Ludden; W A Clementi; S C Harris
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

Review 2.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

3.  Induction of quinidine metabolism and plasma protein binding by phenobarbital in dogs.

Authors:  A Rakhit; N H Holford; D J Effeney; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1984-10

4.  Studies on the excretion of diazepam and nordazepam into milk for the prediction of milk-to-plasma drug concentration ratios.

Authors:  T Stebler; T W Guentert
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.